Massachusetts Eye And Ear Infirmary

This study tested a special contact lens that slowly releases the glaucoma drug latanoprost, aiming to replace daily eye drops. Only one person enrolled before the study was stopped early. The goal was to check if the lens is safe, comfortable, and works to lower eye pressure.

This study tested a prism device to expand the field of view for people who have lost vision in one eye. The goal was to help them detect pedestrians coming from their blind side during a simulated walking task. Only one person participated before the study was ended.

This early study tested the drug AR-42 in 7 adults with vestibular schwannoma or meningioma who were already scheduled for tumor removal surgery. The goal was to see if the drug could lower a protein linked to tumor growth. The study was stopped early, so results are limited.